Chemoinformaics analysis of Hydroxymatairesinol
| Molecular Weight | 374.389 | nRot | 6 |
| Heavy Atom Molecular Weight | 352.213 | nRig | 18 |
| Exact Molecular Weight | 374.137 | nRing | 3 |
| Solubility: LogS | -3.264 | nHRing | 1 |
| Solubility: LogP | 1.839 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 12 |
| nHA | 7 | APOL | 53.6834 |
| nHD | 3 | BPOL | 28.1466 |
| QED | 0.666 |
| Synth | 3.474 |
| Natural Product Likeliness | 1.35 |
| NR-PPAR-gamma | 0.623 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.045 |
| HIA | 0.007 |
| CACO-2 | -4.782 |
| MDCK | 0.0000108 |
| BBB | 0.185 |
| PPB | 0.922577 |
| VDSS | 0.948 |
| FU | 0.13222 |
| CYP1A2-inh | 0.358 |
| CYP1A2-sub | 0.812 |
| CYP2c19-inh | 0.447 |
| CYP2c19-sub | 0.648 |
| CYP2c9-inh | 0.659 |
| CYP2c9-sub | 0.868 |
| CYP2d6-inh | 0.361 |
| CYP2d6-sub | 0.837 |
| CYP3a4-inh | 0.782 |
| CYP3a4-sub | 0.713 |
| CL | 14.92 |
| T12 | 0.868 |
| hERG | 0.141 |
| Ames | 0.07 |
| ROA | 0.067 |
| SkinSen | 0.736 |
| Carcinogencity | 0.206 |
| EI | 0.391 |
| Respiratory | 0.122 |
| NR-Aromatase | 0.608 |
| Antiviral | No |
| Prediction | 0.527857 |